CHRONIC MYELOID LEUKEMIA: EPIDEMIOLOGY AND FIFTEENTH YEARS OF THERAPY IN THE NOVOSIBIRSK REGION

CHRONIC MYELOID LEUKEMIA: EPIDEMIOLOGY AND FIFTEENTH YEARS OF THERAPY IN THE NOVOSIBIRSK REGION

The incidence of chronic myeloid leukemia from 2004 to 2018 amounted to 0.63 per 100 000 people per year. The prevalence of chronic myeloid leukemia over the past 15 years has increased from 1.88 to 7.02 case per 100 000 people. We have analyzed the therapy outcomes of chronic myeloid leukemia of pa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Sibirskiĭ nauchnyĭ medit︠s︡inskiĭ zhurnal 2020-03, Vol.40 (1), p.31-38
Hauptverfasser: A. S. Lyamkina, L. M. Maslova, O. V. Naumenko, E. V. Melnichenko, Yu. N. Obgolts, A. B. Loginova, E. V. Daragan, I. N. Nechunaeva, E. V. Vorontsova, L. A. Shpagina, A. V. Yudanov, K. V. Khalzov, T. I. Pospelova
Format: Artikel
Sprache:eng ; rus
Schlagworte:
chronic myeloid leukemia
complete cytogenetic response
epidemiology
major molecular response
survival
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The incidence of chronic myeloid leukemia from 2004 to 2018 amounted to 0.63 per 100 000 people per year. The prevalence of chronic myeloid leukemia over the past 15 years has increased from 1.88 to 7.02 case per 100 000 people. We have analyzed the therapy outcomes of chronic myeloid leukemia of patients, received imatinib treatment for more than 12 month (165 patients). Complete hematologic response is attained in 88.5 % cases (146 patients), complete cytogenetic response (CCR) (ph+
ISSN:2410-2512
2410-2520
DOI:10.15372/SSMJ20200104